© 2024
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations

OraSure's InteliSwab Test Receives FDA Authorization for Pediatric Use | WDIY Local News

Contributed photo
OraSure Technologies

Bethlehem-based test manufacturer OraSure Technologies announced Monday that its InteliSwab COVID-19 rapid test has received authorization for pediatric use. WDIY’s Sarit Laschinsky has more.

The company says the Food and Drug Administration has authorized InteliSwab for use in children ages 2 to 14. The rapid test was previously authorized for use by adults and children ages 15 to 17 when administered by an adult.

(Original air-date: 2/1/22)

Sarit "Siri" Laschinsky was WDIY's News and Public Affairs Director until 2023.
Related Content